ArticleHeliyon2024
Rare association of posterior reversible encephalopathy syndrome (PRES) with hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome - A case report and review of the literature.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reversible Neurological Manifestations Preceding Biochemical Deterioration in Postpartum HELLP Syndrome-A Case Report and Literature Review.Journal of clinical hypertension (Greenwich, Conn.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The hemolysis-elevated liver enzymes-low platelet counts (HELLP) syndrome and posterior reversible encephalopathy syndrome (PRES) are rare conditions that can complicate pregnancy and the early postpartum period. Although both are closely related to hypertensive pregnancy disorders, their association is rarely described, so the outcome of these patients remains unknown. We present a case report of PRES associated with HELLP syndrome and a review of all previously published cases, including demographic characteristics, clinical presentation, treatment, and outcome. Case presentation: A previously healthy 31-year-old woman in the 38th week of pregnancy was admitted to the obstetric department due to elevated blood pressure. The first laboratory findings were consistent with HELLP, which is why she was delivered by emergency caesarean section. Forty-four hours after the cesarean section, she presented with a severe headache, blurred vision, and instability, followed by two seizures. Magnetic resonance imaging (MRI) of the brain showed T2-weighted/FLAIR left-sided hyperintensity consistent with PRES. She was treated with antihypertensive, antiedematous, and other symptomatic therapy. The control brain MRI showed complete regression of the previously described changes, and she was discharged without a neurological deficit. So far, 33 cases of HELLP associated with PRES have been reported in the literature, including our case. Our review of 30 cases showed that although most patients have good outcomes, if not treated in time, patients may develop serious somatic complications and permanent neurological deficits, or even fatal outcomes. Conclusion: PRES associated with HELLP syndrome is a rare combination of third trimester/postpartum complications which usually present with seizures, altered sensorium, headache, hypertension, and laboratory disorders. These disorders require mutual neurological, internal and gynaecological treatment, and if timely treated resolve completely in most of the cases. However, caution is required as these patients may develop serious somatic complications and permanent neurological deficits or even fatal outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.